Tempus is a health-tech platform that combines genomic, clinical, imaging, and real‑world data into one place using AI, for convenience.

Introduction

Tempus makes good on its mission, “It’s About Time”, by using AI to customize care journeys in oncology, cardiology, radiology, neurology, psychiatry, and depression. It changed its name from Tempus Labs to Tempus AI to demonstrate its increasing devotion to AI. Public since June 14, 2024 (NASDAQ: TEM). With more than 2,300 staff and a CAP/CLIA lab infrastructure in the U.S. and Spain, it seeks to integrate diagnostics, patient information, and generative AI into an integrated health‑tech platform.

Enterprise

AI‑Driven

Multimodal Data

GenAI Assistants

Review

Tempus is a health-tech platform that combines genomic, clinical, imaging, and real‑world data into one place using AI. It provides clinicians, researchers, and pharma firms with tools for precision medicine. Its modular structure, spanning diagnostics, data analytics, cohort formation, trial matching, and care pathway alerts, is one of the most mature in the market. Enterprise‑level deployment is a complexity cost, but for large systems it provides actionable insights at scale.

Features

Genomic & Imaging Diagnostics

NGS sequencing, cardiology and digital‑pathology assays, FDA‑cleared ECG-AF and "al‑gos" diagnostics.

Tempus One

AI clinical assistant for providers, with generative‑AI voice/text query, trial matching, cohort building, evidence retrieval, and order management.

Lens & Cohort Builder

Allows researchers to interrogate multimodal structured and unstructured data with natural language, based on generative‑AI agents.

Loop

Beta oncology target discovery platform that combines real‑world data and CRISPR and organoid models to speed up drug development.

Next

Care pathway intelligence notifies providers about guideline variances in real time through EMR integration (utilized in cardiology and oncology).

Olivia

AI-based mobile health app for patients to consolidate EHR and device data, timeline visualization, and pose questions for summaries; launched beta Jan 2025.

Best Suited for

Healthcare Systems & Hospitals

To provide AI-enabled diagnostics and care-pathway notification at scale (50% of U.S. oncologists connected).

Pharma/Biotech

To create cohorts, pair trials, and identify targets with Loop and de-identified data assets.

Clinicians in Oncology/Cardiology

Utilizing Tempus One and Next to navigate complicated care plans and genomic understanding.

Researchers & Data Scientists

Using Lens and Cohort Builder for real-world evidence and unstructured data mining.

Patients & Caregivers

Through Olivia to summarize health data and get AI-driven summaries.

Strengths

Authentic multimodal data integration, genomics, labs, imaging, real-world data.

FDA-cleared AI tools such as ECG-AF and histogenomics; strong GenAI for cohort and trial matching.

Platform agility, supporting clinicians, enterprises, research, pharma, and patients within a single OS.

Enormous proprietary data (~250 petabytes, 250k+ patients) fueling model enhancement.

Weakness

Enterprise‑sized, complex configuration restricts access by smaller clinics or individuals.

Pricing is opaque and customized, with restricted free or SMB access.

Getting started with: step by step guide

Getting started with Tempus is straight forward:

Step 1: Contact Sales

Go to their website and ask for a demo or implementation call. Enterprise agreements necessary.

Attach lab pipelines, EMR/EHR, imaging systems, or existing databases to Tempus modules.

Select your priority, diagnostic pipelines, care pathway notifications, research cohort access, or patient app.

Utilize FDA‑cleared models and set up thresholds, alerts, and workflows while maintaining compliance.

Deploy to specialties, cancer centers, cardiology units, research teams, etc. Track usage and results.

Frequently Asked Questions

Q: What is Tempus?

A: An artificial-intelligence platform combining diagnostics, multimodal data, and generative-AI with tools for clinicians, researchers, and patients.

A: No consumer tier exists; pricing is enterprise‑level and customized.

A: HIPAA‑compliant infrastructure, de‑identification for research exports, and FDA‑regulated medical devices in place.

Pricing

Not publicly disclosed (enterprise/custom pricing).

Alternatives

Guardant Health

Liquid biopsy pioneer.

Google Health/DeepMind

Research-grades AI within healthcare verticals.

PathAI

AI platform for digital pathology.

Share it on social media:

Leave feedback about this

  • Quality
  • Price
  • Service

Questions and answers of the customers

There are no questions yet. Be the first to ask a question about this product.

Send me a notification for each new answer.
AI Tools Marketplace
Tempus
Tempus is a health-tech platform that combines genomic, clinical, imaging, and real‑world data into one place using AI.